The most important financial indicators for the company Dr. Irimia Srl - Unique Identification Number 21380034:
sales in 2023 was
1.262.821
euro, registering a net profit of
213.831
euro and having an average number of
23
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 32.5%, from 955.840 euro in the year 2022, to 1.262.821 euro in 2023.
The Net Profit decreased by -2.904 euro, from 217.395 euro in 2022, to 213.831 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Dr. Irimia Srl - CUI 21380034
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
128.818
129.736
128.259
127.136
135.248
132.335
185.097
177.707
175.662
171.665
Current Assets
43.001
30.697
25.881
170.194
111.666
74.637
108.586
147.597
326.798
252.645
Inventories
87
191
189
185
182
178
45.723
3.263
4.892
121
Receivables
24.200
16.711
19.336
48.767
123.401
35.797
39.930
100.076
234.219
194.947
Cash
18.714
13.796
6.357
121.242
-11.917
38.662
22.933
44.259
87.687
57.578
Shareholders Funds
39.847
40.180
65.299
222.444
158.699
143.038
47.861
106.054
313.049
140.638
Social Capital
112
112
111
109
107
105
103
101
101
101
Debts
131.972
120.253
88.841
74.887
88.214
63.934
245.823
219.250
190.388
284.645
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8622 - 8622"
CAEN Financial Year
8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
252.645 euro in 2023 which includes Inventories of
121 euro, Receivables of
194.947 euro and cash availability of
57.578 euro.
The company's Equity was valued at
140.638 euro, while total Liabilities amounted to
284.645 euro.
Equity decreased by -171.462 euro, from 313.049 euro in 2022, to 140.638 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Dr. Irimia Srl